5 Value Investing Reads For The Novice Or Pro.

In a simple world driven by economic motive, value is universal. Investors and acquirers want to own it. Entrepreneurs want to create it. Employees want to be it (job security, higher pay). As someone who is relatively inexperienced, but educated, in finance, the concept of value has practical applications beyond…

Read more »

Kill The Company: New Thoughts On Investment

Bruce Berkowitz is famously known among value investors for his “kill the company” strategy, which is part of his investment process; here is what he has said in the past on the topic: “…We try to kill the company. We think of all the ways the company can die, whether it’s…

Read more »

5 Attractive Technology Stocks To Consider For 2012

The technology sector is a large part of many business organizations and it also plays an integral part in the lives of consumers today. Investors may find it hard to resist such a large sector due to the returns generated by some technology companies. In this article, I will focus…

Read more »

Put Rising Gas Prices to Work for You!

As I look back on the first quarter of 2012, one of the most glaring events was the rise in gas prices here in the U.S. Wholesale gasoline began the year at $2.66/gallon on the NYMEX, and closed last Friday at $3.33, a gain of 67 cents … a jaw-dropping…

Read more »

3 Reasons Why This Earnings Season Will Be Different

Only four times a year do we get to take an in-depth, inside look at the health and well-being of major corporations. These four checkpoints can offer important signals on a stock’s journey to glory or oblivion. Ok, maybe that’s a little dramatic…or is it? Most of you already know…

Read more »

How to Use Them: The Top 40 Most Liquid ETFs for Successful Options Trades

Many options traders have requested that I publish my list of 40 ETFs that I follow on a daily basis for the Options Advantage portfolio. Well, per all of your requests I have decided to make my list available for weekly viewing in the Strike Price and daily viewing in…

Read more »

10 Reasons Why The Dollar’s Reign is Almost Over

The U.S. dollar has probably been the closest thing to a true global currency that the world has ever seen.  For decades, the use of the U.S. dollar has been absolutely dominant in international trade.  This has had tremendous benefits for the U.S. financial system and for U.S. consumers, and…

Read more »

This Week’s Market Movers

The market appeared to lose its momentum last week for the first time this year as global growth worries overtook optimism about the U.S. economic scene. Even so, the pullback is modest relative to the gains thus far this year, and could easily get reversed given this week’s potentially market-moving…

Read more »

Oil Heading for Sudden 8% Drop

By Christian DeHaemer (Wealth Daily | Original Link) There has been a lot of talk about the president and his desire to increase the price of oil and gasoline, and replace it with suddenly competitive energy sources like solar, wind, and twisted rubber bands. This week, Obama went to the…

Read more »

Saudi Arabia And China Team Up To Build A Gigantic New Oil Refinery

The largest oil exporter in the Middle East has teamed up with the second largest consumer of oil in the world (China) to build a gigantic new oil refinery and the mainstream media in the United States has barely even noticed it.  This mammoth new refinery is scheduled to be…

Read more »

Jobless Data Shows U.S. Decoupling

This morning’s economic data is giving investors the clearest possible evidence of divergence in global economic growth outlook, with the U.S. economy decoupling from Europe and China. We have another better-than-expected read on Initial Jobless Claims in the U.S., while readings of the manufacturing sector in China and Europe show…

Read more »

Options Call Play Of the Day: ALXN

Alexion Pharma – ALXN – close: 89.81 change: +0.80 Stop Loss: 87.75 Target(s): 98.00 Current Option Gain/Loss: Unopened Time Frame: 3 to 4 weeks New Positions: Yes, see below Company Description Why We Like It: Alexion Pharmaceuticals is a biopharma company. The stock has been stair-stepping higher for weeks. Shares just…

Read more »